Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for fracture prevention in postmenopausal women with osteopenia
ACTRN12609000593235Phase 4Completed
- Sponsor
- Professor Ian Reid
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in osteopenia comparing Zoledronate with Placebo (2 arms). Primary endpoint: Time to first osteoporotic fracture. Started Sep 2009; status: completed.
02
Drugs
zoledronate
03
Conditions
osteopenia
Beyond the preview
Go deeper on ACTRN12609000593235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000593235.